AN2 Therapeutics Stock Jumps 90% Monday: What's Driving The Action?

AN2 Therapeutics Inc (NASDAQ:ANTX) shares are surging Monday afternoon after the clinical-stage biopharmaceutical company announced a $40 million private placement financing. Here’s what investors need to know.AN2 Therapeutics stock is approaching key resistance levels. What’s behind ANTX new highs?AN2 Therapeutics Prices $40M Private Placement With WarrantsAccording to the company, the financing includes the sale of 8,245,611 common shares at $2.85 each, along with pre-funded warrants for up to 5,789,493 a ...